Literature DB >> 27894611

The Threshold Theory for Parkinson's Disease.

Simone Engelender1, Ole Isacson2.   

Abstract

Parkinson's disease (PD) is recognized by the accumulation of α-synuclein within neurons. In contrast to the current ascending theory where α-synuclein would propagate from neuron to neuron, we now propose the threshold theory for PD based on evidence of parallel degeneration of both central nervous system (CNS) and peripheral nervous system (PNS) in PD. The functional threshold is lower for the emergence of early symptoms before the classical motor symptoms of PD. This is due to the larger functional reserve of the midbrain dopamine and integrated basal ganglia motor systems to control movement. This threshold theory better accounts for the current neurobiology of PD symptom progression compared to the hypothesis that the disease ascends from the PNS to the CNS as proposed by Braak's hypothesis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Parkinson's disease; dopaminergic neurons; functional threshold; spreading theory; α-synuclein

Mesh:

Year:  2016        PMID: 27894611     DOI: 10.1016/j.tins.2016.10.008

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  52 in total

1.  Mitochondrial clearance and maturation of autophagosomes are compromised in LRRK2 G2019S familial Parkinson's disease patient fibroblasts.

Authors:  Joanna A Korecka; Ria Thomas; Dan P Christensen; Anthony J Hinrich; Eliza J Ferrari; Simon A Levy; Michelle L Hastings; Penelope J Hallett; Ole Isacson
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

2.  Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models.

Authors:  Pablo Garrido-Gil; Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Mol Neurobiol       Date:  2018-02-05       Impact factor: 5.590

Review 3.  The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.

Authors:  Noémie Cresto; Camille Gardier; Francesco Gubinelli; Marie-Claude Gaillard; Géraldine Liot; Andrew B West; Emmanuel Brouillet
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

Review 4.  Animal models of α-synucleinopathy for Parkinson disease drug development.

Authors:  James B Koprich; Lorraine V Kalia; Jonathan M Brotchie
Journal:  Nat Rev Neurosci       Date:  2017-07-13       Impact factor: 34.870

5.  Nonhuman Primate Models of Neurodegenerative Disorders.

Authors:  Marina E Emborg
Journal:  ILAR J       Date:  2017-12-01

6.  Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.

Authors:  Fredric P Manfredsson; Kelvin C Luk; Matthew J Benskey; Aysegul Gezer; Joanna Garcia; Nathan C Kuhn; Ivette M Sandoval; Joseph R Patterson; Alana O'Mara; Reid Yonkers; Jeffrey H Kordower
Journal:  Neurobiol Dis       Date:  2018-01-16       Impact factor: 5.996

7.  Physiological and pathological roles of LRRK2 in the nuclear envelope integrity.

Authors:  Vered Shani; Hazem Safory; Raymonde Szargel; Ninghan Wang; Tsipora Cohen; Fatimah Abd Elghani; Haya Hamza; Mor Savyon; Inna Radzishevsky; Lihi Shaulov; Ruth Rott; Kah-Leong Lim; Christopher A Ross; Rina Bandopadhyay; Hui Zhang; Simone Engelender
Journal:  Hum Mol Genet       Date:  2019-12-01       Impact factor: 6.150

8.  SUMOylation and ubiquitination reciprocally regulate α-synuclein degradation and pathological aggregation.

Authors:  Ruth Rott; Raymonde Szargel; Vered Shani; Haya Hamza; Mor Savyon; Fatimah Abd Elghani; Rina Bandopadhyay; Simone Engelender
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-27       Impact factor: 11.205

Review 9.  Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.

Authors:  Vinod Metta; Valentina Leta; Kandadai Rukmini Mrudula; L K Prashanth; Vinay Goyal; Rupam Borgohain; Guy Chung-Faye; K Ray Chaudhuri
Journal:  J Neurol       Date:  2021-04-21       Impact factor: 4.849

Review 10.  Prodromal Parkinson disease subtypes - key to understanding heterogeneity.

Authors:  Daniela Berg; Per Borghammer; Seyed-Mohammad Fereshtehnejad; Sebastian Heinzel; Jacob Horsager; Eva Schaeffer; Ronald B Postuma
Journal:  Nat Rev Neurol       Date:  2021-04-20       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.